CSL Seqirus' cell-based influenza vaccine, FLUCELVAX QUAD, will be available on the National Immunisation Program for the 2024 Australian influenza season. …
CSL Seqirus confirms availability of cell-based flu vaccine for 2024 season
February 1, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Private hospitals sustain 230,000 jobs despite $756 million loss
August 31, 2026 - - Other Health -
Alterity secures option underwriting as it prepares for pivotal MSA trial
August 31, 2026 - - Australian Biotech -
Avecho resumes pivotal insomnia trial recruitment after positive interim review
August 31, 2026 - - Australian Biotech -
Tetratherix sends first commercial polymer shipment to United States
August 31, 2026 - - Australian Biotech -
September agenda puts cancer drugs, RSV prevention and ADHD access in focus
August 31, 2026 - - Latest News -
Expansion opens PBS access for more with advanced cancer, but it took a long time
August 31, 2026 - - Latest News -
Funding brings a new targeted treatment for Australians with lupus kidney disease
August 31, 2026 - - Latest News